Your route to faster, non-invasive BCC diagnosis
Simple to adopt • More cost effective for your clinic
Your route to faster,
non-invasive BCC diagnosis
VivoAID brings the power of artificial intelligence directly into your skin cancer clinic.
Trained to automatically detect key basal cell carcinoma (BCC) image markers within VivoSight OCT scans, VivoAID presents clinically relevant findings instantly in an intuitive 3D view.
By accelerating image interpretation and highlighting areas of diagnostic significance, VivoAID supports confident, same-visit decision-making—without biopsy.
How VivoAID supports your clinical workflow
- Supports new OCT users by guiding interpretation with automatically detected BCC image markers
- Accelerates review for experienced users by instantly highlighting marker locations
- Marker Density Histogram rapidly identifies areas of highest diagnostic interest
- Automated measurement of lesion volume and penetration depth
- Full 3D OCT volume rendering for comprehensive lesion assessment
- Highly cost-effective, making OCT easier to learn, faster to use, and simpler to scale
Streamline your skin cancer clinic
Scan, interpret, and assess BCCs in moments.
With VivoAID, clinically actionable diagnostic information is available immediately after a 15-second scan—supporting same-visit diagnosis and commencement of BCC treatment.
Image markers and histogram immediately on display
“The AI tells me upfront where to look in detail… It speeds up the whole process.”
Prof. U. Paasch, Leipzig, Germany
Confident, rapid BCC diagnosis with AI support
The VivoAID algorithm has been trained on thousands of OCT images of BCCs and benign lesions.
It identifies image markers that are internationally recognised by experts as key indicators for BCC diagnosis.
Following a 15-second scan, user-configurable AI image markers are displayed instantly. Regions with the highest marker density are clearly visualised, directing clinician attention to areas of greatest diagnostic relevance and significantly reducing interpretation time.
The Marker Histogram identifies regions of key interest, saving time
Regulatory notice:
VivoAID is provided solely as an educational aid. OCT image analysis and clinical decision-making remain the responsibility of the physician.
Interested? Schedule a Demo Today!
Our team is available for your online demo of VivoSight skin imaging. Complete the form in the link below to schedule a time with one of our experts.
Explore Further
-
Clinical Applications
Learn more about the use of VivoSight OCT in the diagnosis and management of non-melanoma skin cancer (NMSC).
See VivoSight in Practice
Tailored to your clinical or research needs
Book an online demo with our team to see how VivoSight can support your clinical or research workflow.
